Relative Antihypertensive and Glomeruloprotective Efficacies of Enalapril and Candesartan Cilexetil in the Remnant Kidney Model

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System - United Kingdom
doi 10.1177/14703203010020013301
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Biorelevant Dissolution of Candesartan Cilexetil

ADMET and DMPK
PharmacologyHealthMedicineToxicologyChemistryPharmaceutics
2017English

Evaluation of the Pharmacokinetic Interaction Between Candesartan Cilexetil and Felodipine

Journal of Bioequivalence & Bioavailability
2011English

Update on the Clinical Pharmacology of Candesartan Cilexetil

American Journal of Hypertension
Internal Medicine
2000English

Development of Orodispersible Tablets of Candesartan Cilexetil-Β-Cyclodextrin Complex

Journal of Pharmaceutics
2013English

Candesartan Cilexetil/Hydrochlorothiazide Combination Treatment Versus High-Dose Candesartan Cilexetil Monotherapy in Patients With Mild to Moderate Cardiovascular Risk (CHILI Triple T)

Vascular Health and Risk Management
2011English

Anti-Fibrogenic Effects of Captopril and Candesartan Cilexetil on the Hepatic Fibrosis Development in Rat

Experimental and Toxicologic Pathology
MedicineForensic MedicinePathologyCell BiologyToxicology
2003English

Effects of Candesartan Cilexetil on Urinary Protein Excretion in Patients With Essential Hypertension.

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2011English

Candesartan Cilexetil Loaded Solid Lipid Nanoparticles for Oral Delivery: Characterization, Pharmacokinetic and Pharmacodynamic Evaluation

Drug Delivery
MedicinePharmaceutical Science
2014English

Applications and Limitations of Fitting of the Operational Model to Determine Relative Efficacies of Agonists

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy